Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DPLO - Diplomat Pharmacy Inc.


Previous close
4
0   0%

Share volume: 0
Last Updated: Fri 07 Feb 2020 06:00:00 AM CET
Drugstore Chains: 0%

PREVIOUS CLOSE
CHG
CHG%

$4.00
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
58%
Profitability 26%
Dept financing 100%
Liquidity 96%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$4.00
P/E Ratio 
N/A
DAY RANGE
$4.00 - $4.00
EPS 
-$8.68
52 WEEK RANGE
$2.43 - $14.46
52 WEEK CHANGE
-$70.19
MARKET CAP 
303.896 M
YIELD 
N/A
SHARES OUTSTANDING 
75.974 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$57,727,552
AVERAGE 10 VOLUME 
$578,823
AVERAGE 30 VOLUME 
$824,759
Company detail
CEO: Brian T. Griffin
Region: US
Website: http://www.diplomatpharmacy.com
Employees: 2,335
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Drugstore Chains
Sector: Retail Trade

Diplomat Pharmacy, Inc. engages in the provision of specialty pharmacy and infusion services. It operates through the Specialty and Pharmacy Benefit Management segments. The Specialty segment offers a range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost specialty drugs, and a wide range of applications. The Pharmacy Benefit Management segment provides services designed to help the customers reduce the cost and manage the complexity of their prescription drug programs. The company was founded by Dale Hagerman and Philip Hagerman in 1975 and is headquartered in Flint, MI.

Recent news